当前位置:首页 - 行情中心 - 振德医疗(603301) - 财务分析 - 现金流量表

振德医疗

(603301)

  

流通市值:243.56亿  总市值:243.56亿
流通股本:2.64亿   总股本:2.64亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,264,024,831.244,524,475,033.793,512,249,649.922,327,975,913.23
  收到的税费返还48,784,568.93171,995,823.27146,622,791.23100,156,924.91
  收到其他与经营活动有关的现金22,349,040.7386,954,877.7136,339,188.9119,134,730.2
  经营活动现金流入小计1,335,158,440.94,783,425,734.773,695,211,630.062,447,267,568.34
  购买商品、接受劳务支付的现金901,720,485.472,490,239,757.252,047,025,563.821,366,574,378.67
  支付给职工以及为职工支付的现金269,609,250.591,006,585,525.37732,829,927502,248,827.32
  支付的各项税费81,917,476.08337,907,070.94313,138,873.62200,257,035.63
  支付其他与经营活动有关的现金76,157,932.23410,204,651.83339,578,064.3217,478,846.15
  经营活动现金流出小计1,329,405,144.374,244,937,005.393,432,572,428.742,286,559,087.77
  经营活动产生的现金流量净额5,753,296.53538,488,729.38262,639,201.32160,708,480.57
二、投资活动产生的现金流量:
  收回投资收到的现金140,896,358.52636,835,499.61526,391,517.28170,247,865.38
  取得投资收益收到的现金-6,309,500--
  处置固定资产、无形资产和其他长期资产收回的现金净额144,20067,529,017.85628,109.97393,716.81
  投资活动现金流入小计141,040,558.52710,674,017.46527,019,627.25170,641,582.19
  购建固定资产、无形资产和其他长期资产支付的现金80,465,748.77550,215,566.21419,892,275.28310,651,368.58
  投资支付的现金210,370,000657,040,258.4412,040,258.4433,909,258.4
  取得子公司及其他营业单位支付的现金-301,053,947.57301,053,947.57-
  支付其他与投资活动有关的现金3,447,990---
  投资活动现金流出小计294,283,738.771,508,309,772.181,132,986,481.25744,560,626.98
  投资活动产生的现金流量净额-153,243,180.25-797,635,754.72-605,966,854-573,919,044.79
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,673,393.32702,554.25--
  其中:子公司吸收少数股东投资收到的现金2,673,393.32702,554.25--
  取得借款收到的现金105,000,0001,636,500,0001,536,500,0001,500,000,000
  筹资活动现金流入小计107,673,393.321,637,202,554.251,536,500,0001,500,000,000
  偿还债务支付的现金106,000,000937,700,000707,691,361.11630,191,361.11
  分配股利、利润或偿付利息支付的现金5,347,236.48201,493,297.48189,793,055.69183,009,815.61
  支付其他与筹资活动有关的现金4,483,700.9553,664,775.4619,328,346.8610,419,478.94
  筹资活动现金流出小计115,830,937.431,192,858,072.94916,812,763.66823,620,655.66
  筹资活动产生的现金流量净额-8,157,544.11444,344,481.31619,687,236.34676,379,344.34
四、汇率变动对现金及现金等价物的影响-10,686,175.56-13,540,887.78-354,792.694,631,576.53
五、现金及现金等价物净增加额-166,333,603.39171,656,568.19276,004,790.97267,800,356.65
  加:期初现金及现金等价物余额760,989,683.19589,333,115589,333,115589,333,115
  期末现金及现金等价物余额594,656,079.8760,989,683.19865,337,905.97857,133,471.65
补充资料:
  净利润-267,101,815.58-130,653,676.5
  资产减值准备-33,929,277-11,447,368
  固定资产和投资性房地产折旧-268,848,052.17-127,831,052.16
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-268,848,052.17-127,831,052.16
  无形资产摊销-28,530,263.82-13,635,360.85
  长期待摊费用摊销-1,447,939.18-170,364.04
  处置固定资产、无形资产和其他长期资产的损失--637,358.48--340,181.43
  固定资产报废损失-2,033,299.97-237,474.98
  公允价值变动损失--634,530.76--4,795,660.88
  财务费用-36,076,014.41-16,909,899.44
  投资损失--10,458,035.19--1,631,335.23
  递延所得税--1,864,446.99-2,769,295.91
  其中:递延所得税资产减少--445,202.74-4,051,668.21
    递延所得税负债增加--1,419,244.25--1,282,372.3
  存货的减少-1,545,669.93--4,623,387.07
  经营性应收项目的减少--112,165,962.85-28,596,482.59
  经营性应付项目的增加-11,629,675.62--165,759,229.41
  现金的期末余额-760,989,683.19-857,133,471.65
  减:现金的期初余额-589,333,115-589,333,115
  现金及现金等价物的净增加额-171,656,568.19-267,800,356.65
公告日期2026-04-242026-04-242025-10-302025-08-28
审计意见(境内)标准无保留意见
TOP↑